ABSTRACT
Resumo Fundamento: A síndrome de Brugada é um distúrbio arritmogênico hereditário caracterizado pela presença de características eletrocardiográficas específicas com ou sem sintomas. Os pacientes apresentam risco aumentado de morte súbita por fibrilação ventricular. A prevalência desse padrão eletrocardiográfico difere de acordo com a região estudada. Porém, informações epidemiológicas, incluindo a população brasileira, são escassas. Objetivo: Avaliar a prevalência do padrão eletrocardiográfico da síndrome de Brugada e o perfil epidemiológico associado a ela. Métodos: Estudo transversal que incluiu 846.533 registros ECG de 716.973 pacientes do banco de dados de eletrocardiograma (ECG) da Rede de Telemedicina de Santa Catarina por um período de quatro anos. Todos os exames foram ECG de 12 derivações convencionais (sem V1 e V2 em posições altas). Os exames identificados com o diagnóstico de "Síndrome de Brugada" (tipos 1 e 2) foram revisados por um eletrofisiologista. Foram considerados significativos valores de p<0,05. Resultados: Apresentavam padrão potencialmente consistente com ECG do tipo Brugada 83 pacientes. Destes, 33 foram confirmados com padrão de Brugada tipo 1, e 22 com tipo 2, após reavaliação. A prevalência de ECG do tipo 1 de Brugada foi de 4,6 por 100.000 pacientes. O ECG do tipo Brugada 1 foi associado ao sexo masculino (81,8% vs. 41,5%, p<0,001) e menor prevalência de obesidade (9,1% vs. 26,4%, p=0,028). Conclusões: Este estudo mostrou baixa prevalência de ECG do tipo Brugada no sul do Brasil. A presença de ECG com padrão Brugada tipo 1 esteve associada ao sexo masculino e menor prevalência de obesidade que a população geral.
Abstract Background: Brugada Syndrome is an inherited arrhythmogenic disorder characterized by the presence of specific electrocardiographic features with or without clinical symptoms. The patients present increased risk of sudden death due to ventricular fibrillation. The prevalence of this electrocardiographic pattern differs according to the studied region. However, epidemiological information including the Brazilian population is scarce. Objectives: To assess the prevalence of the electrocardiographic pattern of Brugada syndrome and the epidemiological profile associated with it. Methods: Cross-sectional study that included 846,533 ECG records of 716,973 patients from the electrocardiogram (ECG) database from the Santa Catarina Telemedicine Network over a 4-year period. All tests were 12-lead conventional ECG (without V1 and V2 in high positions). The tests revealing "Brugada Syndrome" diagnosis (Types 1 and 2) were reviewed by a cardiac electrophysiologist. The level of significance was set at p<0.05. Results: In total, 83 patients had a pattern potentially consistent with Brugada-type pattern ECG. Of these, 33 were confirmed having Brugada-type 1, and 22 with type 2 ECG after reevaluation. The prevalence of Brugada-type 1 ECG was 4.6 per 100,000 patients. Brugada-type 1 ECG was associated with the male gender (81.8% vs. 41.5%, p<0.001) and a lower prevalence of obesity diagnosis (9.1% vs. 26.4%, p=0.028). Conclusions: This study showed low prevalence of Brugada-type ECG in Southern Brazil. The presence of Brugada-type 1 ECG was associated with the male gender and lower prevalence of obesity diagnosis comparing to the general population.
Subject(s)
Humans , Male , Brugada Syndrome/diagnosis , Brugada Syndrome/epidemiology , Brazil/epidemiology , Prevalence , Cross-Sectional Studies , ElectrocardiographyABSTRACT
We report a 20-year-old male athlete who while running, presented a sudden death due to ventricular fibrillation. He was successfully rescued by cardiopulmonary resuscitation maneuvers and an automatic external defibrillator. Without evidence of structural heart disease, Brugada syndrome was diagnosed as the cause, after which a subcutaneous implantable cardioverter defibrillator was indicated. We discuss the subject of sudden cardiac death in athletes and its unusual relationship with exercise in this channelopathy.
Subject(s)
Humans , Male , Adult , Young Adult , Cardiopulmonary Resuscitation , Defibrillators, Implantable , Brugada Syndrome/complications , Brugada Syndrome/diagnosis , Arrhythmias, Cardiac , Death, Sudden, Cardiac/etiologyABSTRACT
Resumen Comunicamos el caso de un hombre de 56 años que ingresó por pericarditis aguda febril, probablemente de causa viral, que durante su evolución presentó una fibrilación auricular paroxística y taquicardia ventricular polimorfa recurrente. El análisis de la historia clínica y serie electrocardiográfica permitió el diagnóstico retrospectivo asociado de un síndrome de Brugada. Hubo buena respuesta inicial al tratamiento antiinflamatorio asociado a colchicina y se implantó un desfibrilador automático intracavitario para prevención de muerte súbita. Se discuten aspectos clínicos del síndrome de Brugada, la importancia de la fiebre y de la pericarditis como cuadro clínico asociado.
Abstract A 56-year-old patient was admitted for acute febrile pericarditis, probably viral, who presented with paroxysmal atrial fibrillation and recurrent polymorphic ventricular tachycardia during his clinical course. Analysis of the clinical and electrocardiographic findings allowed the retrospective diagnosis of Brugada syndrome in the context of pericarditis. An initial response to anti-inflammatory treatment associated with colchicine was good. An internal cardioverter defibrillator was implanted to prevent sudden death. Clinical aspects of the Brugada syndrome, the importance of fever and pericarditis as an associated clinical condition are discussed.
Subject(s)
Humans , Male , Middle Aged , Pericarditis/complications , Pericarditis/diagnosis , Brugada Syndrome/complications , Brugada Syndrome/diagnosis , Atrial Fibrillation/etiology , Tachycardia, Ventricular/etiology , ElectrocardiographyABSTRACT
We report a 44-year-old male who was admitted for Influenza B and fever, presenting a type I Brugada pattern on the electrocardiogram. He evolved without cardiovascular symptoms. The pharmacological test with intravenous Procainamide reproduced type I Brugada pattern and the programmed electrical stimulation was negative for ventricular arrhythmias. He was discharged without incidents. Clinical aspects of Brugada syndrome and the importance of fever are discussed in the current context of the COVID-19 pandemic.
Subject(s)
Adult , Humans , Male , Influenza, Human/diagnosis , Brugada Syndrome , Influenza B virus , Electrocardiography , Brugada Syndrome/diagnosisABSTRACT
A 61-year-old female patient with history of hipertension is scheduled to undergo a minor ginecological procedure (endoscopic endometrial polipus resection) with general anesthesia. She received standard monitorization, induction with midazolam, propofol and fentanyl. Ventilated with laringeal mask. Anesthesia was maintained with sevoflurane, nitrous oxide and oxygen. During surgical procedure, the patient received atropine and ephedrine associated with two episodes of bradycardia without hemodinamic disturbances. The surgery ended without problems. During the weaking up process she presented characteristical waves of ventricular fibrillation, recuperating sinusal rhythm secondary to defibrillation with 360 J. There was no clear cause for cardiac arrest at that moment so patient was translated to the ICU for observation, monitoring and study. Postoperative EKG presented an ascending ST segment in V to V derivations without hemodynamic alterations associated. The possible diagnosis of Brugada's Syndrome was proposed. The patient received an implantable defibrillator. The mechanisms and anesthetic implications are discussed and reviewed.
Paciente de 61 años, hipertensa, fue sometida a un procedimiento endoscópico menor (histeroscopía) bajo anestesia general balanceada. Recibió monitorización estándar, inducción con midazolam, propofol y fentanilo. Se ventiló con máscara laríngea y la mantención anestésica fue con sevoflurano asociado a NO en O. En dos oportunidades recibió atropina y efedrina para el manejo de bradicardias sin compromiso hemodinámico. Se completó el procedimiento ginecológico sin complicaciones. Durante el despertar anestésico, presentó una fibrilación ventricular que cedió con desfibrilación. Se estabilizó y trasladó a UCI donde se estudió las posibles etiologías. Se obtiene ECG postoperatorio con elevación del segmento ST en derivaciones Va V sin alteraciones hemodinámicas asociadas, postulándose un síndrome de Brugada. Se le instaló desfibrilador implantable. Se revisa y discuten los diversos mecanismos e implicancias anestésicas asociadas.
Subject(s)
Humans , Female , Middle Aged , Hysteroscopy , Anesthetics, General/administration & dosage , Brugada Syndrome/complications , Brugada Syndrome/diagnosis , Heart Arrest/etiology , Postoperative Complications , Electric Countershock , Diagnosis, Differential , Heart Arrest/therapyABSTRACT
Um dos grandes desafios no atendimento dos pacientes nas unidades de emergência é o tratamento das arritmias ventriculares, principalmente, quando sustentadas e recorrentes, pois são de difícil tratamento e estão associadas à alta mortalidade. O principal mecanismo envolvido na sustentação das taquicardias ventriculares é o mecanismo de reentrada, devido às cicatrizes miocárdicas secundárias a diversas cardiopatias estruturais. A tempestade elétrica pode ser séria quando ocorre em portadores de desfibriladores automáticos, provocando múltiplos choques correspondentes fora do ambiente hospitalar. Nesses casos é necessária a internação hospitalar, onde medidas específicas e escalonadas de tratamento são realizadas, indo desde o manejo clínico até intervenções específicas, como programação de dispositivos eletrônicos, intervenções eletrofisiológicas ou cirúrgicas
One of the biggest challenges in the care of patients in emergency units is the treatment of ventricular arrhythmias, particularly when sustained and relapsing, as they are difficult to treat and are associated with high mortality. The main mechanism involved in the maintenance of ventricular tachycardias is the mechanism of reentry, due to myocardial scars secondary to various structural heart diseases. The electrical storm may be serious when it occurs in patients with automatic defibrillators, causing multiple corresponding shocks outside the hospital setting. In these cases, admission to hospital is necessary, where specific and stepwise treatment measures are performed, ranging from clinical management to specific interventions, such as programming of electronic devices, and electrophysiological or surgical interventions
Subject(s)
Humans , Male , Female , Pacemaker, Artificial , Arrhythmias, Cardiac/diagnosis , Arrhythmias, Cardiac/therapy , Tachycardia, Ventricular/diagnosis , Tachycardia, Ventricular/therapy , Propranolol/therapeutic use , Quinidine/therapeutic use , Verapamil/therapeutic use , Electric Stimulation Therapy/methods , Defibrillators , Diagnosis, Differential , Electrocardiography/methods , Brugada Syndrome/diagnosis , Brugada Syndrome/therapy , Heart , Heart Diseases/diagnosis , Amiodarone/therapeutic useSubject(s)
Humans , Male , Young Adult , Exercise/physiology , Exercise Test , Brugada Syndrome/diagnosis , ElectrocardiographyABSTRACT
As arritmias hereditárias são responsáveis por uma proporção significante de mortes cardíacas súbitas em indivíduos jovens aparentemente saudáveis. As canalopatias, como síndrome de Brugada, síndrome do QT longo/curto e taquicardia ventricular polimórfica catecolaminérgica, contribuem com essa incidência e não são marcadas por anomalias estruturais. A cardiomiopatia genética, como cardiomiopatia arritmogênica doventrículo direito e cardiomiopatia hipertrófica, também são causas de morte súbita por arritmia. Novos consensos têm sido publicados para orientar melhor as ferramentas dediagnóstico, os escores de estratificação e o tratamento. Os testes genéticos têm papel importante no diagnóstico, na estratificação de risco e no tratamento de pacientes e de suas famílias. Os avanços da genética molecular nas duas últimas décadas revelaram a base genética subjacente da doença, e podem levar a tratamentos mais personalizados...
Inherited arrhythmias account for a significant proportion of sudden cardiac deaths in apparently healthy and young individuals. Ion channelopathies such as Brugada syndrome, long/short QT syndrome and catecholaminergic polymorphic ventricular tachycardiacontribute to this incidence and are marked by no structural abnormalities. Genetic cardiomyopathy such as Right Ventricular Arrhythmogenic Cardiomyopathy and HypertrophicCardiomyopathy are also causes of arrhythmogenic sudden death. New consensuses are published to better guide the diagnostic tools, stratification scores and treatment. Genetic testing plays somehow an important role in the diagnosis, risk-stratification and treatment of patients and family members. Molecular genetic advances in the last 2 decades have revealed the underlying genetic basis and these may lead to a personalized medicine...
Subject(s)
Humans , Arrhythmias, Cardiac/genetics , Arrhythmias, Cardiac/therapy , Genetic Diseases, Inborn/therapy , Long QT Syndrome/diagnosis , Long QT Syndrome/genetics , Tachycardia, Ventricular/genetics , Tachycardia, Ventricular/therapy , Cardiomyopathy, Hypertrophic/therapy , Electrocardiography/methods , Propranolol , Sotalol/administration & dosage , Brugada Syndrome/diagnosis , Brugada Syndrome/therapy , Heart VentriclesABSTRACT
Brugada syndrome is an autosomal dominant genetic disorder associated with an increased risk of sudden cardiac death, as well as ventricular tachyarrhythmias.The defective cardiac sodium channels result in usual electrocardiographic findings of a coved-type ST elevation in precordial leads V1 to V3. The majority of patients have uncomplicated courses with anesthesia, surgery, and invasive procedures. However there is risk of worsening ST elevation and ventricular arrhythmias due to perioperative medications, surgical insult, electrolyte abnormalities, fever, autonomic nervous system tone, as well as other perturbations. Given the increasing numbers of patients with inherited conduction disorders presenting for non-cardiac surgery that are at risk of sudden cardiac death, safe anesthetic management depends upon a detailed knowledge of these conditions.
Subject(s)
Anesthesia , Arrhythmias, Cardiac , Brugada Syndrome/chemically induced , Brugada Syndrome/diagnosis , Brugada Syndrome/epidemiology , Brugada Syndrome/genetics , Brugada Syndrome/physiopathology , Humans , Perioperative PeriodABSTRACT
In 1992 a new syndrome was described consisting of syncopal episodes or sudden death in patients with a structurally normal heart and an electrocardiogram characteristic of right bundle branch block with ST segment elevation in leads V1 to V3. Brugada syndrome is an autosomal dominant disorder. It has been shown to be associated with mutations in the gene (SCN5A) that encodes for the sodium ion channel in cardiac myocyte. Over 160 mutations of gene SCN5A have been identifi ed. Th e incidence of the disease is diffi cult to estimate, but it causes sudden deaths of 5 per 10,000 inhabitants per year and involved much more frequently in people of Asian ancestry. Diagnosis can be easily made by means of genetic analysis and ECG. Recent data suggest that loss of the action potential dome in the right ventricular epicardium underlies ST segment elevation seen in this syndrome. Right ventricular epicardium is preferentially aff ected because of the predominance of transient outward current in this tissue. Antiarrhythmic drugs like amiodarone and beta-blockers do not prevent death in symptomatic or asymptomatic individuals. Th ough Implantation of an automatic cardioverter–defi brillator is the only recently proven eff ective therapy; Quinidine has been found to decrease Ventricular fi brillation and could prove to be a secured option of implantable cardioverter–defi brillator. However, researcher set focus on gene therapy that may off er an enduring cure in future years. Th e purpose of this brief review is to record the past highlights that have brought us to our present understanding of Brugada syndrome.
Subject(s)
Asian People , Arrhythmias, Cardiac/drug therapy , Arrhythmias, Cardiac/etiology , Brugada Syndrome/complications , Brugada Syndrome/diagnosis , Brugada Syndrome/mortality , Death, Sudden, Cardiac/etiology , Humans , Tachycardia, Ventricular/drug therapy , Tachycardia, Ventricular/etiologyABSTRACT
El síndrome de Brugada es una enfermedad hereditaria caracterizada por una anormalidad electrocardiográfica y un aumento del riesgo de muerte súbita cardiaca. El síndrome de Brugada puede ser causado por la presencia de mutaciones en el gen SCN5A en aproximadamente el 20% de los casos familiares. El gen SCN5A codifica la subunidad a del canal iónico de sodio en las células cardiacas. Estudios realizados durante la última década en genética molecular han permitido identificar 11 nuevos genes con susceptibilidad para síndrome de Brugada además del SCN5A, lo que lleva a pensar que es una enfermedad con heterogeneidad genética y compleja de identificar en la clínica y a nivel molecular en el laboratorio. Una manera de heredar el síndrome de Brugada es por medio de un patrón de transmisión hereditaria autosómica dominante. Esta breve revisión se enfoca a describir el proceso de diagnóstico de marcadores genéticos en un caso reportado de síndrome de Brugada guiando al lector a través del proceso de identificación de las variantes genéticas responsables del síndrome y a determinar la consecuencia funcional de las mutaciones del canal de sodio sobre la alteración electrocardiográfica.
Brugada syndrome is a genetic disease that is characterized by abnormal electrocardiogram findings and an increased risk of sudden cardiac death. This syndrome is linked to mutations in the SCN5A gene in approximately 20% of Brugada syndrome probands. SCN5A encodes the a subunit of the cardiac sodium channel. Studies conducted over the past decade have identified 11 other Brugada syndrome susceptibility genes besides to SCN5A, pointing to genetic heterogeneity of the syndrome. Transmission of the disease shows an autosomal dominant inheritance pattern. This brief review focuses on a reported case of sodium channel-mediated Brugada syndrome, guiding the reader through the process of identification of the genetic variants responsible for the clinically-diagnosed syndrome, mutagenesis to clone SCN5A with and without the 2 variants identified and transfection of the 2 variants into TSA201 cells to determine the functional consequence of these genetic variants on sodium channel expression and function.
Subject(s)
Humans , Male , Brugada Syndrome/genetics , /genetics , Brugada Syndrome/diagnosis , Mutation , PedigreeABSTRACT
We report a 22-year-old male who experienced several episodes of syncope within a timeframe of few hours. In the emergency room, multiple ventricular fibrillation episodes where documented along with a type 1 Brugada ECG pattern. Isoproterenol in continuous infusion was started, normalizing the ECG and avoiding further arrhythmia recurrences. The patient was implanted with an automated defibrillator and discharged 3 days after admission.
Subject(s)
Humans , Male , Young Adult , Adrenergic beta-Agonists/therapeutic use , Brugada Syndrome/drug therapy , Isoproterenol/therapeutic use , Brugada Syndrome/diagnosis , Defibrillators, Implantable , Electrocardiography , Treatment Outcome , Ventricular Fibrillation/drug therapyABSTRACT
O caso clínico sugere uma forma rara de canalopatia mista, cujo sintoma clínico e eletrocardiográfico indicava taquicardia ventricular polimórfica catecolaminérgica (TVPC). Porém, ao realizar o teste ergométrico, no pós-esforço, quando há predomínio do sistema nervoso parassimpático, nota-se a indução de eletrocardiograma (ECG) compatível com Brugada do tipo I. Outro aspecto importante foi a transmissão hereditária observada neste caso, em que os avós do paciente eram primos de primeiro grau e houve seis casos de morte súbita cardíaca (MSC) nas gerações subsequentes, com irmão que teve MSC aos 5 anos durante uma crise de choro, mostrando um importante fator genético e familiar relacionado às canalopatias.
The clinical case suggests a rare form of mixed channelopathy, whose clinical and electrocardiographic symptom suggested catecholaminergic polymorphic ventricular tachycardia (CPVT). However, when the exercise test was performed, during post-exercise, where there is a predominance of the parasympathetic nervous system, there was an electrocardiogram (ECG) induction compatible with Brugada type I. Another important aspect was the hereditary transmission observed in this patient, whose grandfathers were first cousins, and 6 cases of sudden cardiac death (SCD) were observed in subsequent generations and one brother had SCD at 5 years of age during a crying episode, showing an important genetic and familial factor related to channelopathies.
Subject(s)
Humans , Male , Adult , Nadolol/administration & dosage , Procainamide/administration & dosage , Brugada Syndrome/diagnosis , Tachycardia, Ventricular/nursing , Channelopathies , Defibrillators, Implantable , Electrocardiography , Death, Sudden/prevention & controlABSTRACT
Brugada syndrome can be unmasked by several conditions including a febrile state, marked leukocytosis, and electrolyte disturbances. Herein, we describe a 62-year-old man with cholangiocarcinoma in the first reported case of Brugada syndrome onset following photodynamic therapy.
Subject(s)
Humans , Male , Middle Aged , Bile Duct Neoplasms/drug therapy , Bile Ducts, Intrahepatic , Brugada Syndrome/diagnosis , Cardiopulmonary Resuscitation , Cholangiocarcinoma/drug therapy , Electrocardiography , Fatal Outcome , Fever/etiology , Klatskin Tumor/drug therapy , Photochemotherapy/adverse effects , Predictive Value of Tests , Treatment OutcomeABSTRACT
Apesar de ter completado 100 anos de existência, o eletrocardiograma ainda é o primeiro exame complementar solicitado para avaliação cardiológica de um paciente. A incorporação de modernos recursos da eletrônica e da informática desenvolveu muito os eletrocardiográfos, mas as bases do registro do sinal elétrico emitido pelo coração permanecem as mesmas. Entretanto, ao longo do século XX, os conhecimentos adquiridos a partir do eletrocardiograma não permaneceram estáticos. A eletrofisiologia clínica contribuiu muito para elucidar os mecanismos das arritmias cardíacas. O reconhecimento de novas doenças diagnosticáveis apenas pelo eletrocardiograma, como as síndromes do QT longo e de Brugada, causadas por modificações genéticas dos canais iônicos, transformou o eletrocardiograma em mensageiro molecular das células do coração. No infarto agudo do miocárdio, estudos baseados em evidências...
Subject(s)
Humans , Male , Bradycardia/prevention & control , Hypocalcemia/diagnosis , Hypothyroidism/prevention & control , Brugada Syndrome/diagnosis , Anti-Arrhythmia Agents/adverse effects , Electrocardiography, Ambulatory , Potassium/adverse effects , Potassium/blood , Sodium/bloodABSTRACT
A displasia arritmogênica do ventrículo direito (DAVD) é caracterizada pela substituição dos miócitos por tecido fibrogorduroso. Descrita em 1977, é considerada uma doença cardíaca potencialmente letal ainda pouco entendida. Afeta primariamente o ventrículo direito e tem sido associada a arritmias, insuficiência cardíaca e morte súbita. O objetivo deste artigo é descrever o caso clínico de um paciente de 25 anos com síncope associada a extra-sístoles ventriculares e achados de ressonância magnética do coração compatíveis com DAVD.
Arritmogenic right ventricular dysplasia (ARVD) is characterized by the gradual replacement of myocytes by adipose and fibrous tissue. Described in 1977, is considered a potentially lethal cause of cardiac disease poorly understood. This disorder usually involves the right ventricle and has been associated with arrthymia, heart failure, and sudden death. In this paper, we report a case of a 25-years-old patient with syncope associated with ventricular extrasystoles. A magnetic resonance imaging was performed and showed findings that support ARVD diagnose.